Medication Use Performance Indicator Evaluation

Résumé du livre

ABSTRACT: In the first step, database analysis, medication use performance indicators (MU-PI) were used to estimate the number of PDRM positives in the managed care organization?s administrative database. Step two used the Delphi process to judge the degree of association between select MU-PIs and specific nodes of the medication use system (MUS) where the process failure may have originated. In step three, select MU-PIs from each node of the MUS were submitted to cause-and-effect analysis (CEA). Results: The period prevalence for process positives was 209.84 (206.37-213.34) per 1,000 member years. The period prevalence for PDRM positives was 1.98 (1.6-2.4) per 1,000 member years. Gender, number of office visits, number of drug classes and number of medical conditions were independent risk factors for PDRM. Fourteen indicators were selected for step two.